GlassScriptPhysician profile
Debra K Nelson
NPI 1245470095
$1,374.45
in general payments reported to CMS, 2019-2025
19 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $394 · 2023: $561 · 2024: $186 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $244.09 | 2022-2024 | Phexxi |
| Sumitomo Pharma America, INC. | $193.48 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $192.42 | 2022-2025 | |
| Myovant Sciences INC. | $166.74 | 2022 | |
| Exeltis, USA INC. | $92.43 | 2022-2023 | Slynd |
| Shield Therapeutics INC | $72.14 | 2022-2023 | Accrufer |
| Abbvie INC. | $57.06 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $51.81 | 2023 | Exparel |
| Millicent US INC | $48.58 | 2024 | Femring, Intrarosa |
| Baxter Healthcare | $41.57 | 2023 | Tisseel |
| Coopersurgical, INC. | $39.14 | 2022-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $27.15 | 2025 | Aptima |
| Dexcom, INC. | $24.10 | 2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $23.62 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $22.64 | 2023 | Balcoltra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.62 | 2023 | |
| Mylan Pharmaceuticals INC. | $20.02 | 2022 | |
| Organon LLC | $19.54 | 2024 | |
| Exact Sciences Corporation | $16.30 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.